These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37886951)

  • 21. Combination of mTOR and EGFR kinase inhibitors blocks mTORC1 and mTORC2 kinase activity and suppresses the progression of colorectal carcinoma.
    Wang Q; Wei F; Li C; Lv G; Wang G; Liu T; Bellail AC; Hao C
    PLoS One; 2013; 8(8):e73175. PubMed ID: 23991179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repression of protein synthesis and mTOR signaling in rat liver mediated by the AMPK activator aminoimidazole carboxamide ribonucleoside.
    Reiter AK; Bolster DR; Crozier SJ; Kimball SR; Jefferson LS
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E980-8. PubMed ID: 15613684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA-dependent protein kinase regulates lysosomal AMP-dependent protein kinase activation and autophagy.
    Puustinen P; Keldsbo A; Corcelle-Termeau E; Ngoei K; Sønder SL; Farkas T; Kaae Andersen K; Oakhill JS; Jäättelä M
    Autophagy; 2020 Oct; 16(10):1871-1888. PubMed ID: 31983282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship.
    Jhanwar-Uniyal M; Wainwright JV; Mohan AL; Tobias ME; Murali R; Gandhi CD; Schmidt MH
    Adv Biol Regul; 2019 May; 72():51-62. PubMed ID: 31010692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
    Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
    Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling.
    Julien LA; Carriere A; Moreau J; Roux PP
    Mol Cell Biol; 2010 Feb; 30(4):908-21. PubMed ID: 19995915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling.
    Bolster DR; Crozier SJ; Kimball SR; Jefferson LS
    J Biol Chem; 2002 Jul; 277(27):23977-80. PubMed ID: 11997383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR).
    García-Martínez JM; Moran J; Clarke RG; Gray A; Cosulich SC; Chresta CM; Alessi DR
    Biochem J; 2009 Jun; 421(1):29-42. PubMed ID: 19402821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney.
    Pearce LR; Sommer EM; Sakamoto K; Wullschleger S; Alessi DR
    Biochem J; 2011 May; 436(1):169-79. PubMed ID: 21413931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
    Tong JF; Yan X; Zhu MJ; Du M
    J Cell Biochem; 2009 Oct; 108(2):458-68. PubMed ID: 19639604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions between mTORC2 core subunits Rictor and mSin1 dictate selective and context-dependent phosphorylation of substrate kinases SGK1 and Akt.
    Yu Z; Chen J; Takagi E; Wang F; Saha B; Liu X; Joubert LM; Gleason CE; Jin M; Li C; Nowotny C; Agard D; Cheng Y; Pearce D
    J Biol Chem; 2022 Sep; 298(9):102288. PubMed ID: 35926713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of mTOR inhibitor PP242 and AMPK activator metformin exerts enhanced inhibitory effects on colorectal carcinoma cells in vitro by blocking multiple kinase pathways.
    Sun C; Yang X; Jin Z; Gao Z
    J Chemother; 2023 May; 35(3):259-269. PubMed ID: 35731713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysine suppresses myofibrillar protein degradation by regulating the autophagic-lysosomal system through phosphorylation of Akt in C2C12 cells.
    Sato T; Ito Y; Nagasawa T
    Springerplus; 2014; 3():584. PubMed ID: 25332884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5'-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside.
    Jakobsen SN; Hardie DG; Morrice N; Tornqvist HE
    J Biol Chem; 2001 Dec; 276(50):46912-6. PubMed ID: 11598104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Digitoxin Suppresses Human Cytomegalovirus Replication via Na
    Mukhopadhyay R; Venkatadri R; Katsnelson J; Arav-Boger R
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29321306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AICAR treatment for 14 days normalizes obesity-induced dysregulation of TORC1 signaling and translational capacity in fasted skeletal muscle.
    Drake JC; Alway SE; Hollander JM; Williamson DL
    Am J Physiol Regul Integr Comp Physiol; 2010 Dec; 299(6):R1546-54. PubMed ID: 20844264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?
    Corton JM; Gillespie JG; Hawley SA; Hardie DG
    Eur J Biochem; 1995 Apr; 229(2):558-65. PubMed ID: 7744080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxin-induced tail phosphorylation of hepatocellular S6 kinase: evidence for a dual involvement of the AMP-activated protein kinase in S6 kinase regulation.
    Møller MT; Samari HR; Seglen PO
    Toxicol Sci; 2004 Dec; 82(2):628-37. PubMed ID: 15342961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-derived growth factor-induced Akt phosphorylation requires mTOR/Rictor and phospholipase C-γ1, whereas S6 phosphorylation depends on mTOR/Raptor and phospholipase D.
    Razmara M; Heldin CH; Lennartsson J
    Cell Commun Signal; 2013 Jan; 11(1):3. PubMed ID: 23311350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological inhibition of mTORC1 but not mTORC2 protects against human disc cellular apoptosis, senescence, and extracellular matrix catabolism through Akt and autophagy induction.
    Kakiuchi Y; Yurube T; Kakutani K; Takada T; Ito M; Takeoka Y; Kanda Y; Miyazaki S; Kuroda R; Nishida K
    Osteoarthritis Cartilage; 2019 Jun; 27(6):965-976. PubMed ID: 30716534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.